This trial found that the use of botulinum toxin type A significantly improved the appearance of glabellar lines.
1 Primary · 1 Secondary · Reporting Duration: Week 1, 2, 4, 8, 12, 18
Experimental Treatment
Non-Treatment Group
72 Total Participants · 32 Treatment Groups
Primary Treatment: AI-09 Dose 3 · Has Placebo Group · Phase 1 & 2
Participation is compensated
You will be compensated for participating in this trial.
Age 20 - 70 · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Florida | 100.0% |
18 - 65 | 100.0% |
Baumann Cosmetic & Research Institute | 100.0% |
Met criteria | 100.0% |